Home Whistleblower Claims Life Spine Inc. Whistleblower Claim

Life Spine Inc. Whistleblower Claim

Seeger Weiss LLP represented four former employees who blew the whistle on Life Spine, Inc., a medical device maker accused of paying surgeons to use and promote its products. The case was ultimately resolved for nearly $6 million.

Resolved

Prior results do not guarantee or predict a similar outcome in any future matter.

Last updated: Apr 17, 2024
Life Spine Inc. Whistleblower Claim

What’s on this page:

Firm News

October 3, 2024
Seeger Weiss Partner Jennifer Scullion Appointed Plaintiff’s Steering Committee Co-Chair in Change Healthcare Data Breach Litigation

RIDGEFIELD PARK, NJ – Seeger Weiss partner Jennifer Scullion has been appointed as co-chair of the Plaintiff’s Steering Committee for the Provider Track by the Honorable Judge Donovan W. Frank in the Change Healthcare, Inc. Customer Data Security Breach Litigation. The multidistrict litigation centralized in the District of Minnesota consolidates nearly 50 class action lawsuits […]

Read More
September 17, 2024
Seeger Weiss Named Regional Powerhouse by Law360

Seeger Weiss has been honored with the 2024 Regional Powerhouse Award from Law360, recognizing the firm’s pivotal role in shaping the legal landscape in New Jersey and beyond. Known for its leadership in complex litigation and significant contributions to mass torts, environmental law, product liability, and eDiscovery, Seeger Weiss remains dedicated to providing our high […]

Read More
September 9, 2024
Seven Seeger Weiss Partners Named to 2025 Lawdragon 500 Leading Litigators in America List

Seeger Weiss is proud to announce that seven partners — Chris Seeger, Stephen Weiss, David Buchanan, Shauna Itri, Parvin Aminolroaya, Matt Pawa, and Jennifer Scullion — have been named to the 2025 Lawdragon 500 Leading Litigators in America list. This prestigious guide, first published in 2007, seeks to highlight 500 of the most distinguished litigators […]

Read More
September 6, 2024
Seeger Weiss Partner Parvin Aminolroaya Featured on CBS News Discussing Ozempic Litigation

Seeger Weiss partner Parvin Aminolroaya recently appeared on CBS News to discuss ongoing litigation against pharmaceutical companies Novo Nordisk and Eli Lilly over their popular GLP-1 receptor agonist medications such as Ozempic, Wegovy, Mounjaro, and Zepbound. Our firm represents patients across the country who allege they suffered serious medical complications while taking these drugs and […]

Read More